These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28083789)

  • 1. Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.
    Kalantari E; Asgari M; Nikpanah S; Salarieh N; Asadi Lari MH; Madjd Z
    Pathol Oncol Res; 2017 Oct; 23(4):793-802. PubMed ID: 28083789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD44 and CD133 protein expression might serve as a prognostic factor for early occurrence castration-resistant prostate cancer.
    Dwina Y; Zaid LSM; Saraswati M; Rachmadi L; Kekalih A; Rahadiani N; Louisa M; Agustina H; Mochtar CA; Hamid ARAH
    Prostate; 2024 Jun; 84(8):738-746. PubMed ID: 38528654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of putative cancer stem cell markers (CD24, CD44, CD133, and ALDH1) in human papillary thyroid carcinoma.
    Han SA; Jang JH; Won KY; Lim SJ; Song JY
    Pathol Res Pract; 2017 Aug; 213(8):956-963. PubMed ID: 28687160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancerous and non-neoplastic stem cells in the stomach similarly express CD44 and CD133.
    Feitosa NPP; Pereira VBM; Silva BGB; Queroz AVF; Rodrigues BJ; Costa MLV; Alencar CH; Lima-Júnior RCP; Wong DVT; Frota CC; Almeida PRC
    Acta Histochem; 2021 Oct; 123(7):151787. PubMed ID: 34517259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study.
    Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK
    Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer.
    Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M
    Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of the expression of cancer stem cell-related markers CD133 and CD44 in hepatocellular carcinoma: From patients to patient-derived tumor xenograft models.
    Zhao Q; Zhou H; Liu Q; Cao Y; Wang G; Hu A; Ruan L; Wang S; Bo Q; Chen W; Hu C; Xu D; Tao F; Cao J; Ge Y; Yu Z; Li L; Wang H
    Oncotarget; 2016 Jul; 7(30):47431-47443. PubMed ID: 27329727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis.
    Durko L; Wlodarski W; Stasikowska-Kanicka O; Wagrowska-Danilewicz M; Danilewicz M; Hogendorf P; Strzelczyk J; Malecka-Panas E
    Dis Markers; 2017; 2017():3276806. PubMed ID: 28659655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD133+/CD44+ prostate cancer stem cells exhibit embryo-like behavior patterns.
    Acikgoz E; Soner BC; Ozdil B; Guven M
    Acta Histochem; 2021 Jul; 123(5):151743. PubMed ID: 34157581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermethylation of Cyclin D2 is associated with loss of mRNA expression and tumor development in prostate cancer.
    Henrique R; Costa VL; Cerveira N; Carvalho AL; Hoque MO; Ribeiro FR; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    J Mol Med (Berl); 2006 Nov; 84(11):911-8. PubMed ID: 17016690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent 14-3-3 sigma promoter methylation in benign and malignant prostate lesions.
    Henrique R; Jerónimo C; Hoque MO; Carvalho AL; Oliveira J; Teixeira MR; Lopes C; Sidransky D
    DNA Cell Biol; 2005 Apr; 24(4):264-9. PubMed ID: 15812243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate.
    Yamamoto H; Masters JR; Dasgupta P; Chandra A; Popert R; Freeman A; Ahmed A
    PLoS One; 2012; 7(10):e46979. PubMed ID: 23071686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cancer stem cell-related markers in different stages of colorectal carcinoma patients of Indian origin by immunohistochemistry.
    Chaitra LP; Prashant A; Gowthami CS; Hajira B; Suma MN; Mahesh SS; Manjunath GV; Sheeladevi CS
    J Cancer Res Ther; 2019; 15(1):75-81. PubMed ID: 30880758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic significance of putative stem cell markers, CD44 and nestin, in gastric adenocarcinoma.
    Dhingra S; Feng W; Brown RE; Zhou Z; Khoury T; Zhang R; Tan D
    Int J Clin Exp Pathol; 2011; 4(8):733-41. PubMed ID: 22135720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
    Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers.
    Simon RA; di Sant'Agnese PA; Huang LS; Xu H; Yao JL; Yang Q; Liang S; Liu J; Yu R; Cheng L; Oh WK; Palapattu GS; Wei J; Huang J
    Hum Pathol; 2009 Feb; 40(2):252-8. PubMed ID: 18835619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of epithelial/stromal caveolin-1 expression in prostatic hyperplasia, high grade prostatic intraepithelial hyperplasia and prostatic carcinoma and its correlation with microvessel density.
    Mohammed DA; Helal DS
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):25-31. PubMed ID: 28259631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.